J
Jeffrey J. Presneill
Researcher at Royal Melbourne Hospital
Publications - 122
Citations - 7287
Jeffrey J. Presneill is an academic researcher from Royal Melbourne Hospital. The author has contributed to research in topics: Intensive care & Randomized controlled trial. The author has an hindex of 37, co-authored 110 publications receiving 6201 citations. Previous affiliations of Jeffrey J. Presneill include Alfred Hospital & Royal Brisbane and Women's Hospital.
Papers
More filters
Journal ArticleDOI
Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock
James A. Russell,Keith R. Walley,Joel Singer,Anthony C. Gordon,Paul C. Hébert,D. James Cooper,Cheryl L. Holmes,Sangeeta Mehta,John Granton,Michelle Storms,Deborah J. Cook,Jeffrey J. Presneill,Dieter Ayers +12 more
TL;DR: Low-dose vasopressin did not reduce mortality rates as compared with norepinephrine among patients with septic shock who were being treated with conventional (catecholamine) vasopressesors, and a test for heterogeneity between these two study strata was not significant.
Journal ArticleDOI
Pulmonary alveolar proteinosis: progress in the first 44 years.
TL;DR: There has been rapid progress toward elucidation of the molecular mechanisms underlying both the congenital and acquired forms of pulmonary alveolar proteinosis, following serendipitous discoveries in gene-targeted mice lacking granulocyte-macrophage colony-stimulating factor.
Journal ArticleDOI
Feasibility and inter-rater reliability of the ICU Mobility Scale
Carol L. Hodgson,Dale M. Needham,Kimberley J Haines,Michael Bailey,Alison Ward,Megan Harrold,Paul J Young,Jennifer M. Zanni,Heidi Buhr,Alisa Higgins,Jeffrey J. Presneill,Susan C Berney +11 more
TL;DR: The IMS is a feasible tool with strong inter-rater reliability for measuring the maximum level of mobility of adult patients in the ICU and can be used for evaluating mobility and rehabilitation activities for research and clinical care purposes.
Journal ArticleDOI
Early mobilization and recovery in mechanically ventilated patients in the ICU: a bi-national, multi-centre, prospective cohort study
Carol L. Hodgson,Rinaldo Bellomo,Susan C Berney,Michael Bailey,Heidi Buhr,Linda Denehy,Megan Harrold,Alisa Higgins,Jeffrey J. Presneill,Manoj Saxena,Elizabeth H Skinner,Paul J Young,Steven A R Webb +12 more
TL;DR: More than 50% of patients discharged from the ICU had developed ICU-acquired weakness, which was associated with death between ICU discharge and day-90, and 6-month functional recovery including return to work at 6 months among mechanically ventilated ICU patients.
Journal ArticleDOI
Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis
John F. Seymour,Jeffrey J. Presneill,Otto D. Schoch,Gordon H. Downie,Paul E. Moore,Ian R. Doyle,Janette M. Vincent,Koh Nakata,Takayuki Kitamura,David Langton,Michael C. Pain,Ashley R. Dunn +11 more
TL;DR: It is concluded that GM- CSF has therapeutic activity in idiopathic AP, providing a potential alternative to whole-lung lavage, and was well-tolerated, with no late toxicity seen.